Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study
This study showed an increase in the dispensation of GLP-1 RA, with characteristics of patients changing towards a higher degree of off-label use. The effectiveness and safety of the increasing prescriptions warrant future studies.
Authors
- Annica Fors
- Björn Wettermark (ORCID: https://orcid.org/0000-0003-0531-2516)
- Anders Sundström (ORCID: https://orcid.org/0000-0003-2337-3371)
- Tomas Forslund (ORCID: https://orcid.org/0000-0002-2001-7710)
Institutions
- Uppsala University (SE)
- Medical Products Agency (SE)
- Karolinska Institutet (SE)
- Healthcare in Sweden (SE)
- Stockholm Health Care Services (SE)
Publication Details
- Journal
- European Journal of Clinical Pharmacology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1007/s00228-025-03823-9
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Uppsala Universitet